PASTRx, New Software for Doctors to Help Treat Pain & Reduce Abuse of Controlled Substances, Introduced by Philadelphia Tech Firm

Prescription Advisory Systems & Technology Develops Advanced Software for Safer Prescribing of Controlled Substances

Jenkintown, Pennsylvania – April 24, 2015 – You can see the passion for the issue in Rick Bunker’s eyes, as he explains the growing problem of accidental overdoses of prescription medication, and the need for a better way for doctors to treat patients in pain.

It is out of that concern for what he found to be a challenge in the healthcare system, that Bunker has created a solution.  He and his colleagues at Prescription Advisory Systems and Technology (P.A.S.T.) have just introduced a new software platform called PASTRx for doctors to help treat patients with chronic pain, and reduce the abuse of controlled substances.

“I began to realize the extent of the problems two years ago on a social visit to my best friend from high school, who is now a primary care doctor,” said Bunker.  “He said that he was afraid he had been turned into a gatekeeper for narcotics.  Everything about him wants to figure out why his patient has chronic back pain and how he can help them, but he has to play detective first and try to figure out if a first-time patient is only trying to get narcotics – it interferes with the proper relationship of the doctor and the patient.

“Because of issues like this, doctors are increasingly turning down new chronic pain patients because they can’t be sure, and they know that the problem is growing, as prescription drug overdoses have recently passed auto accidents as the leading cause of accidental death in the United States.”

Bunker partnered with Dr. F. Stuart Leeds, MD to come up with protocols for opiates and controlled substances -- a way to help doctors to identify troubling patterns in a patient’s controlled substance history.

They co-founded Prescription Advisory Systems and Technology (P.A.S.T.) in 2013, and earlier this month introduced their premier software solution, PASTRx into the medical technology marketplace after more than two years of research and development.

Bunker noted, “A new patient comes to a doctor for the first time, the doctor notices that the patient is in pain.  How can the doctor know if this is a complex patient, who needs intervention for addiction, or the care of a pain specialist? What we’ve done with PASTRx is take the proper and recommended protocols and embody as many of those protocols into our software. 

“We pull in the data,” said Bunker.  “When a patient goes in to see a doctor, the doctor can call on our PASTRx system, we pull in the data from the doctor’s own electronic health system, what prescriptions he has written for that patient, lab tests and test results, and combine it with the data from the state Prescription Drug Monitoring Program (PDMP) database that has been populated by pharmacists in the state.  We can even show the locations of other doctors and other pharmacies and other geographical data as needed, giving that medical provider all the relevant data they need to properly care for their patient.”

PASTRx helps medical providers follow professional recommendations that they check a state’s PDMP for a patients’ controlled substance prescription history.  PASTRx gives medical practitioners significant added value to the PDMP data (currently required in 22 states), by integrating data from multiple sources including the Centers for Disease Control , with the patient’s electronic medical data file.  In addition, PASTRx provides medical providers with a sophisticated, patent-pending analysis of the patient’s records, with advanced graphic visualization technology that can be viewed directly on a laptop computer or tablet while the patient is in a doctor’s treatment room.

The PASTRx system quickly delivers intuitive views of patient’s controlled substance prescription history, within the clinical workflow.  Since PDMPs were originally designed for law enforcement without consideration of time-sensitivity, it’s often challenging for medical providers to gain their needed protection and value from PDMPs in the urgency of the clinical setting.    PASTRx compiles the data and delivers an analysis rapidly to medical providers to make an immediate diagnosis.

“I’ve been making software for a long time now, but in so many ways this is the most important software I’ve ever been associated with,” Bunker said.  “With PASTRx, we are giving doctors facts, not just a collection of data, but facts about those patients that they can then use in a conversation with the patient.  It gives doctors a much better chance to identify and help people getting in trouble with their medication.  They don’t have to spend five minutes of their consulting time trying to get an honest answer out of a patient, they can just go ahead and treat the patient with the facts they now have in front of them. 

“Additionally, PASTRx provides the medical practice with a record that all this data was checked, so that if the DEA does need an answer on a possible issue, that medical practice has a full and complete record it can present.  The patient is protected, the doctor is protected, and the institution is protected.”

PASTRx has just debuted in the market, and is intended for use by any medical professional who is called upon to write controlled substance prescriptions, from primary care doctors, who write the majority of all prescriptions, to pain specialists, neurologists, oral surgeons and orthopedists. 

Bunker brings over 25 years of executive experience to P.A.S.T., specializing in general management and software development team leadership, especially in venture and PE backed companies. He has held executive level technology positions for three publicly traded companies – SEIC, ICGE, GSIC (now a division of eBay) – and was CEO of Reality Online, a Reuter’s subsidiary that was a pioneer in internet delivery of consumer financial services. In addition to his technology leadership, Bunker has worked on over 100 M&A transactions. He is a veteran of the United States Army Security Agency, a graduate of the Defense Language Institute and attended Boston University, studying Russian Language and Literature. 

Dr. Leeds, M.S., M.D., completed his undergraduate studies at the University of Cincinnati, majoring in chemistry, with a minor in Judaic studies. He is a graduate of the Case Western Reserve University School of Medicine in Cleveland, where he obtained both the M.D. degree and an M.S. in pharmacology. In 1998, he completed a family medicine residency at the Medical College of Virginia/Chippenham program in Richmond. With an interest in rural practice, he spent the next seven years in a hospital-owned group practice in Mt. Orab, Ohio. In 2006, he took a position with the Clinton Memorial Hospital in Wilmington, Ohio, during which time he was appointed as adjunct faculty at the University of Cincinnati, with part-time teaching duties at the UC/Wilmington Family Medicine Residency Program. Two years later, he joined the full-time core faculty as assistant professor of family medicine and director of medical student education. He joined the Boonshoft School of Medicine faculty in 2014. His professional duties and interests include pre-doctoral education, chronic pain management and medical informatics. 

P.A.S.T. is supported by Ben Franklin Technology Partners of Southeastern, PA, an initiative of the Pennsylvania Department of Community and Economic Development funded by Ben Franklin Technology Development Authority.

About P.A.S.T.:

Prescription Advisory Systems & Technology (P.A.S.T.) is a technology company which helps doctors to prescribe controlled substance medications safely and confidently. The company’s premier subscription analytics software, PASTRx, integrates, correlates and analyzes data from multiple sources, both public and private, to identify patients who might need treatment for tolerance or addiction, and to clear the way for confident treatment of the rest. This protects patients, and simultaneously reduces prescriber and institutional exposure to civil and criminal liability.  Additional information is available at

Media Contact: Jim DeLorenzo, Jim DeLorenzo Public Relations, 215-266-5943,